Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
fortune.com
A joint study between Yale University, King’s College Hospital in London and Doctors Without Borders found a single shot could be made for just 89 cents.

cross-posted from: https://mander.xyz/post/11304633

Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5

  • 0xvalentin@lemmy.sdf.orgEnglish
    12·
    7 months ago

    I read the article and I don’t think it factors in the upfront cost of R&D, Compliance, etc, so that’s basically a fantasy number.

    • seriousconsideration@lemmy.dbzer0.comEnglish
      3·
      7 months ago

      You’re probably right. It’s more than likely the cost per dose. Which is also what the $1000 figure represents.

      The Vermont independent (Bernie) called on Novo Nordisk to lower the list price of Ozempic to $155 a month or less, in line with what it charges in other countries.

      Somehow they can justify selling it for $155 a dose (per month?) in other countries while still making a profit above the overhead and compliance costs.

    • Banzai51@midwest.socialEnglish
      3·
      7 months ago

      Those are the costs of doing business, and can be greatly exaggerated. And other counties produce profitable drugs even with price restrictions. We’re so accustomed to price gouging, that we don’t recognize it.